ISOPP Disclaimer for OPAB and UTIC

The International Society of Oncology Pharmacy Practitioners (ISOPP)’s education course UTIC and OPAB supports knowledge and understanding of oncology pharmacy professionals and includes both basics and advanced concepts.

Every healthcare facility may have different policies and procedures in regard to oncology pharmacy practice. The text, photos and videos presented in this program have been developed considering international scenario and needs of anticipated participants.

The content is for educational purposes only and may contain some copyrighted materials from biology textbooks, medical periodicals, articles and websites. Wherever possible, the authors of such materials have been contacted for permission to use and/or adapt such materials; a reference or link is provided to the original source.

The authors have made every effort to ensure that the information presented was accurate at the time of publication. As new research and experience broadens our knowledge, changes will be considered. The authors, reviewers, ISOPP and Pfizer are NOT responsible for errors, omissions, inconsistencies or continued completeness of the information contained in the OPAB or UTIC Program.

ISOPP is not liable for any information provided in the content of the OPAB or UTIC programs. ISOPP hereby disclaims all liability for any claims, losses or damages in connection with use or application of these materials.

Disclosures OPAB

This educational initiative was funded by an educational grant from Pfizer. Author disclosures are listed in each Module.

Ownership

Disclosures UTIC

This education program has been supported by a partial grant from Roche Products Limited and Incyte Biosciences UK Ltd. Roche Products Limited and Incyte Biosciences UK Ltd have had no control or influence over the educational content of this program.